<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2023//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_230101.dtd">
<PubmedArticleSet>
<PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Automated"><PMID Version="1">37014017</PMID><DateCompleted><Year>2023</Year><Month>06</Month><Day>19</Day></DateCompleted><DateRevised><Year>2023</Year><Month>06</Month><Day>19</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">2328-9503</ISSN><JournalIssue CitedMedium="Internet"><Volume>10</Volume><Issue>6</Issue><PubDate><Year>2023</Year><Month>Jun</Month></PubDate></JournalIssue><Title>Annals of clinical and translational neurology</Title><ISOAbbreviation>Ann Clin Transl Neurol</ISOAbbreviation></Journal><ArticleTitle>Dynamic effects of prognostic factors and individual survival prediction for amyotrophic lateral sclerosis disease.</ArticleTitle><Pagination><StartPage>892</StartPage><EndPage>903</EndPage><MedlinePgn>892-903</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1002/acn3.51771</ELocationID><Abstract><AbstractText Label="OBJECTIVE" NlmCategory="OBJECTIVE">Amyotrophic lateral sclerosis (ALS) is a neurodegenerative disease affecting motor neurons, with broad heterogeneity in disease progression and survival in different patients. Therefore, an accurate prediction model will be crucial to implement timely interventions and prolong patient survival time.</AbstractText><AbstractText Label="METHODS" NlmCategory="METHODS">A total of 1260 ALS patients from the PRO-ACT database were included in the analysis. Their demographics, clinical variables, and death reports were included. We constructed an ALS dynamic Cox model through the landmarking approach. The predictive performance of the model at different landmark time points was evaluated by calculating the area under the curve (AUC) and Brier score.</AbstractText><AbstractText Label="RESULTS" NlmCategory="RESULTS">Three baseline covariates and seven time-dependent covariates were selected to construct the ALS dynamic Cox model. For better prognostic analysis, this model identified dynamic effects of treatment, albumin, creatinine, calcium, hematocrit, and hemoglobin. Its prediction performance (at all landmark time points, AUC&#x2009;&#x2265;&#x2009;0.70 and Brier score&#x2009;&#x2264;&#x2009;0.12) was better than that of the traditional Cox model, and it predicted the dynamic 6-month survival probability according to the longitudinal information of individual patients.</AbstractText><AbstractText Label="INTERPRETATION" NlmCategory="CONCLUSIONS">We developed an ALS dynamic Cox model with ALS longitudinal clinical trial datasets as the inputs. This model can not only capture the dynamic prognostic effect of both baseline and longitudinal covariates but also make individual survival predictions in real time, which are valuable for improving the prognosis of ALS patients and providing a reference for clinicians to make clinical decisions.</AbstractText><CopyrightInformation>&#xa9; 2023 The Authors. Annals of Clinical and Translational Neurology published by Wiley Periodicals LLC on behalf of American Neurological Association.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Huang</LastName><ForeName>Baoyi</ForeName><Initials>B</Initials><AffiliationInfo><Affiliation>Department of Biostatistics, School of Public Health (Guangdong Provincial Key Laboratory of Tropical Disease Research), Southern Medical University, Guangzhou, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Geng</LastName><ForeName>Xiang</ForeName><Initials>X</Initials><AffiliationInfo><Affiliation>Department of Biostatistics, School of Public Health (Guangdong Provincial Key Laboratory of Tropical Disease Research), Southern Medical University, Guangzhou, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Yu</LastName><ForeName>Zhiyin</ForeName><Initials>Z</Initials><AffiliationInfo><Affiliation>Department of Biostatistics, School of Public Health (Guangdong Provincial Key Laboratory of Tropical Disease Research), Southern Medical University, Guangzhou, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Zhang</LastName><ForeName>Chengfeng</ForeName><Initials>C</Initials><AffiliationInfo><Affiliation>Department of Biostatistics, School of Public Health (Guangdong Provincial Key Laboratory of Tropical Disease Research), Southern Medical University, Guangzhou, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Chen</LastName><ForeName>Zheng</ForeName><Initials>Z</Initials><Identifier Source="ORCID">0000-0003-3201-2666</Identifier><AffiliationInfo><Affiliation>Department of Biostatistics, School of Public Health (Guangdong Provincial Key Laboratory of Tropical Disease Research), Southern Medical University, Guangzhou, China.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><GrantList CompleteYN="Y"><Grant><GrantID>2022A1515011525</GrantID><Agency>Guangdong Basic and Applied Basic Research Foundation</Agency><Country/></Grant><Grant><GrantID>82173622</GrantID><Agency>National Natural Science Foundation of China</Agency><Country/></Grant><Grant><GrantID>81673268</GrantID><Agency>National Natural Science Foundation of China</Agency><Country/></Grant><Grant><GrantID>82073675</GrantID><Agency>National Natural Science Foundation of China</Agency><Country/></Grant></GrantList><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2023</Year><Month>04</Month><Day>04</Day></ArticleDate></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>Ann Clin Transl Neurol</MedlineTA><NlmUniqueID>101623278</NlmUniqueID><ISSNLinking>2328-9503</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D011379" MajorTopicYN="N">Prognosis</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000690" MajorTopicYN="Y">Amyotrophic Lateral Sclerosis</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D019636" MajorTopicYN="Y">Neurodegenerative Diseases</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D018450" MajorTopicYN="N">Disease Progression</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D016016" MajorTopicYN="N">Proportional Hazards Models</DescriptorName></MeshHeading></MeshHeadingList><CoiStatement>All authors have no relevant financial or non&#x2010;financial interests to disclose.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="revised"><Year>2023</Year><Month>3</Month><Day>22</Day></PubMedPubDate><PubMedPubDate PubStatus="received"><Year>2023</Year><Month>1</Month><Day>27</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2023</Year><Month>3</Month><Day>23</Day></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2023</Year><Month>6</Month><Day>19</Day><Hour>13</Hour><Minute>8</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2023</Year><Month>4</Month><Day>5</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2023</Year><Month>4</Month><Day>4</Day><Hour>7</Hour><Minute>24</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">37014017</ArticleId><ArticleId IdType="pmc">PMC10270250</ArticleId><ArticleId IdType="doi">10.1002/acn3.51771</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Atassi N, Berry J, Shui A, et&#xa0;al. The PRO&#x2010;ACT database: design, initial analyses, and predictive features. Neurology. 2014;83(19):1719&#x2010;1725. doi:10.1212/WNL.0000000000000951</Citation><ArticleIdList><ArticleId IdType="doi">10.1212/WNL.0000000000000951</ArticleId><ArticleId IdType="pmc">PMC4239834</ArticleId><ArticleId IdType="pubmed">25298304</ArticleId></ArticleIdList></Reference><Reference><Citation>Kiernan MC, Vucic S, Talbot K, et&#xa0;al. Improving clinical trial outcomes in amyotrophic lateral sclerosis. Nat Rev Neurol. 2021;17(2):104&#x2010;118. doi:10.1038/s41582-020-00434-z</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41582-020-00434-z</ArticleId><ArticleId IdType="pmc">PMC7747476</ArticleId><ArticleId IdType="pubmed">33340024</ArticleId></ArticleIdList></Reference><Reference><Citation>Gola D, K&#xf6;nig IR. Empowering individual trait prediction using interactions for precision medicine. BMC Bioinformatics. 2021;22(1):74. doi:10.1186/s12859-021-04011-z</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s12859-021-04011-z</ArticleId><ArticleId IdType="pmc">PMC7890638</ArticleId><ArticleId IdType="pubmed">33602124</ArticleId></ArticleIdList></Reference><Reference><Citation>Westeneng HJ, Debray TPA, Visser AE, et&#xa0;al. Prognosis for patients with amyotrophic lateral sclerosis: development and validation of a personalised prediction model. Lancet Neurol. 2018;17(5):423&#x2010;433. doi:10.1016/S1474-4422(18)30089-9</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S1474-4422(18)30089-9</ArticleId><ArticleId IdType="pubmed">29598923</ArticleId></ArticleIdList></Reference><Reference><Citation>Spencer KR, Foster ZW, Rauf NA, et&#xa0;al. Neuropathological profile of long&#x2010;duration amyotrophic lateral sclerosis in military veterans. Brain Pathol. 2020;30(6):1028&#x2010;1040. doi:10.1111/bpa.12876</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/bpa.12876</ArticleId><ArticleId IdType="pmc">PMC8018169</ArticleId><ArticleId IdType="pubmed">32633852</ArticleId></ArticleIdList></Reference><Reference><Citation>Zandon&#xe0; A, Vasta R, Chi&#xf2; A, Di Camillo B. A dynamic Bayesian network model for the simulation of amyotrophic lateral sclerosis progression. BMC Bioinformatics. 2019;20(suppl. 4):118. doi:10.1186/s12859-019-2692-x</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s12859-019-2692-x</ArticleId><ArticleId IdType="pmc">PMC6471677</ArticleId><ArticleId IdType="pubmed">30999865</ArticleId></ArticleIdList></Reference><Reference><Citation>Lacomblez L, Bensimon G, Leigh PN, et&#xa0;al. Dose&#x2010;ranging study of riluzole in amyotrophic lateral sclerosis. Amyotrophic Lateral Sclerosis/Riluzole Study Group II. Lancet. 1996;347(9013):1425&#x2010;1431. doi:10.1016/s0140-6736(96)91680-3</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/s0140-6736(96)91680-3</ArticleId><ArticleId IdType="pubmed">8676624</ArticleId></ArticleIdList></Reference><Reference><Citation>Abe K, Aoki M, Tsuji S, et&#xa0;al. Safety and efficacy of edaravone in well defined patients with amyotrophic lateral sclerosis: a randomised, double&#x2010;blind, placebo&#x2010;controlled trial. Lancet Neurol. 2017;16(7):505&#x2010;512. doi:10.1016/S1474-4422(17)30115-1</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S1474-4422(17)30115-1</ArticleId><ArticleId IdType="pubmed">28522181</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhou N, Manser P. Does including machine learning predictions in ALS clinical trial analysis improve statistical power? Ann Clin Transl Neurol. 2020;7(10):1756&#x2010;1765. doi:10.1002/acn3.51140</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/acn3.51140</ArticleId><ArticleId IdType="pmc">PMC7545604</ArticleId><ArticleId IdType="pubmed">32862509</ArticleId></ArticleIdList></Reference><Reference><Citation>Le&#xe3;o T, Madeira SC, Gromicho M, de Carvalho M, Carvalho AM. Learning dynamic Bayesian networks from time&#x2010;dependent and time&#x2010;independent data: unraveling disease progression in amyotrophic lateral sclerosis. J Biomed Inform. 2021;117:103730. doi:10.1016/j.jbi.2021.103730</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jbi.2021.103730</ArticleId><ArticleId IdType="pubmed">33737206</ArticleId></ArticleIdList></Reference><Reference><Citation>Watanabe H, Atsuta N, Nakamura R, et&#xa0;al. Factors affecting longitudinal functional decline and survival in amyotrophic lateral sclerosis patients. Amyotroph Lateral Scler Frontotemporal Degener. 2015;16(3&#x2013;4):230&#x2010;236. doi:10.3109/21678421.2014.990036</Citation><ArticleIdList><ArticleId IdType="doi">10.3109/21678421.2014.990036</ArticleId><ArticleId IdType="pubmed">25548957</ArticleId></ArticleIdList></Reference><Reference><Citation>Bald EM, Nance CS, Schultz JL. Melatonin may slow disease progression in amyotrophic lateral sclerosis: findings from the pooled resource open&#x2010;access ALS clinic trials database. Muscle Nerve. 2021;63(4):572&#x2010;576. doi:10.1002/mus.27168</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/mus.27168</ArticleId><ArticleId IdType="pmc">PMC8842494</ArticleId><ArticleId IdType="pubmed">33428242</ArticleId></ArticleIdList></Reference><Reference><Citation>Chen L, Zhang B, Chen R, et&#xa0;al. Natural history and clinical features of sporadic amyotrophic lateral sclerosis in China. J Neurol Neurosurg Psychiatry. 2015;86(10):1075&#x2010;1081. doi:10.1136/jnnp-2015-310471</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/jnnp-2015-310471</ArticleId><ArticleId IdType="pubmed">26124198</ArticleId></ArticleIdList></Reference><Reference><Citation>Wei Q, Chen X, Zheng Z, et&#xa0;al. The predictors of survival in Chinese amyotrophic lateral sclerosis patients. Amyotroph Lateral Scler Frontotemporal Degener. 2015;16(3&#x2013;4):237&#x2010;244. doi:10.3109/21678421.2014.993650</Citation><ArticleIdList><ArticleId IdType="doi">10.3109/21678421.2014.993650</ArticleId><ArticleId IdType="pubmed">25581512</ArticleId></ArticleIdList></Reference><Reference><Citation>Marin B, Couratier P, Arcuti S, et&#xa0;al. Stratification of ALS patients' survival: a population&#x2010;based study. J Neurol. 2016;263(1):100&#x2010;111. doi:10.1007/s00415-015-7940-z</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00415-015-7940-z</ArticleId><ArticleId IdType="pubmed">26518423</ArticleId></ArticleIdList></Reference><Reference><Citation>Reniers W, Schrooten M, Claeys KG, et&#xa0;al. Prognostic value of clinical and electrodiagnostic parameters at time of diagnosis in patients with amyotrophic lateral sclerosis. Amyotroph Lateral Scler Frontotemporal Degener. 2017;18(5&#x2013;6):341&#x2010;350. doi:10.1080/21678421.2017.1288254</Citation><ArticleIdList><ArticleId IdType="doi">10.1080/21678421.2017.1288254</ArticleId><ArticleId IdType="pubmed">28631957</ArticleId></ArticleIdList></Reference><Reference><Citation>Van Houwelingen HC. Dynamic prediction by landmarking in event history analysis. Scand J Stat. 2017;34(1):70&#x2010;85. doi:10.1111/j.1467-9469.2006.00529.x</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/j.1467-9469.2006.00529.x</ArticleId></ArticleIdList></Reference><Reference><Citation>Yang Z, Hou Y, Lyu J, Liu D, Chen Z. Dynamic prediction and prognostic analysis of patients with cervical cancer: a landmarking analysis approach. Ann Epidemiol. 2020;44:45&#x2010;51. doi:10.1016/j.annepidem.2020.01.009</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.annepidem.2020.01.009</ArticleId><ArticleId IdType="pubmed">32220511</ArticleId></ArticleIdList></Reference><Reference><Citation>Yang Z, Wu H, Hou Y, Yuan H, Chen Z. Dynamic prediction and analysis based on restricted mean survival time in survival analysis with nonproportional hazards. Comput Methods Programs Biomed. 2021;207:106155. doi:10.1016/j.cmpb.2021.106155</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.cmpb.2021.106155</ArticleId><ArticleId IdType="pubmed">34038865</ArticleId></ArticleIdList></Reference><Reference><Citation>
PRO&#x2010;ACT Data Set. Accessed August 2022. https://nctu.partners.org/PROACT
</Citation></Reference><Reference><Citation>Bedlack RS, Vaughan T, Wicks P, et&#xa0;al. How common are ALS plateaus and reversals? Neurology. 2016;86(9):808&#x2010;812. doi:10.1212/WNL.0000000000002251</Citation><ArticleIdList><ArticleId IdType="doi">10.1212/WNL.0000000000002251</ArticleId><ArticleId IdType="pmc">PMC4793781</ArticleId><ArticleId IdType="pubmed">26658909</ArticleId></ArticleIdList></Reference><Reference><Citation>Cox DR. Regression models and life&#x2010;tables. J R Stat Soc Series B Stat Methodol. 1972;34(2):187&#x2010;202. doi:10.1111/j.2517-6161.1972.tb00899.x</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/j.2517-6161.1972.tb00899.x</ArticleId></ArticleIdList></Reference><Reference><Citation>Lobo JM, Jim&#xe9;nez&#x2010;Valverde A, Real R. AUC: a misleading measure of the performance of predictive distribution models. Glob Ecol Biogeogr. 2008;17(2):145&#x2010;151. doi:10.1111/j.1466-8238.2007.00358.x</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/j.1466-8238.2007.00358.x</ArticleId></ArticleIdList></Reference><Reference><Citation>Gerds TA, Schumacher M. Consistent estimation of the expected brier score in general survival models with right&#x2010;censored event times. Biom J. 2006;48(6):1029&#x2010;1040. doi:10.1002/bimj.200610301</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/bimj.200610301</ArticleId><ArticleId IdType="pubmed">17240660</ArticleId></ArticleIdList></Reference><Reference><Citation>Creemers H, Grupstra H, Nollet F, van den Berg LH, Beelen A. Prognostic factors for the course of functional status of patients with ALS: a systematic review. J Neurol. 2015;262(6):1407&#x2010;1423. doi:10.1007/s00415-014-7564-8</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00415-014-7564-8</ArticleId><ArticleId IdType="pubmed">25385051</ArticleId></ArticleIdList></Reference><Reference><Citation>Ong ML, Tan PF, Holbrook JD. Predicting functional decline and survival in amyotrophic lateral sclerosis. PLoS ONE. 2017;12(4):e0174925. doi:10.1371/journal.pone.0174925</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pone.0174925</ArticleId><ArticleId IdType="pmc">PMC5390993</ArticleId><ArticleId IdType="pubmed">28406915</ArticleId></ArticleIdList></Reference><Reference><Citation>Wei QQ, Chen Y, Cao B, et&#xa0;al. Blood hemoglobin A1c levels and amyotrophic lateral sclerosis survival. Mol Neurodegener. 2017;12(1):69. doi:10.1186/s13024-017-0211-y</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s13024-017-0211-y</ArticleId><ArticleId IdType="pmc">PMC5609007</ArticleId><ArticleId IdType="pubmed">28934974</ArticleId></ArticleIdList></Reference><Reference><Citation>McCombe PA, Henderson RD. Effects of gender in amyotrophic lateral sclerosis. Gend Med. 2010;7(6):557&#x2010;570. doi:10.1016/j.genm.2010.11.010</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.genm.2010.11.010</ArticleId><ArticleId IdType="pubmed">21195356</ArticleId></ArticleIdList></Reference><Reference><Citation>Schumacher M, Hieke S, Ihorst G, Engelhardt M. Dynamic prediction: a challenge for biostatisticians, but greatly needed by patients, physicians and the public. Biom J. 2020;62(3):822&#x2010;835. doi:10.1002/bimj.201800248</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/bimj.201800248</ArticleId><ArticleId IdType="pubmed">30908745</ArticleId></ArticleIdList></Reference><Reference><Citation>Tavazzi E, Daberdaku S, Zandon&#xe0; A, et&#xa0;al. Predicting functional impairment trajectories in amyotrophic lateral sclerosis: a probabilistic, multifactorial model of disease progression. J Neurol. 2022;269(7):3858&#x2010;3878. doi:10.1007/s00415-022-11022-0</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00415-022-11022-0</ArticleId><ArticleId IdType="pmc">PMC9217910</ArticleId><ArticleId IdType="pubmed">35266043</ArticleId></ArticleIdList></Reference><Reference><Citation>Finnerup NB, Haroutounian S, Baron R, et&#xa0;al. Neuropathic pain clinical trials: factors associated with decreases in estimated drug efficacy. Pain. 2018;159(11):2339&#x2010;2346. doi:10.1097/j.pain.0000000000001340</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/j.pain.0000000000001340</ArticleId><ArticleId IdType="pmc">PMC6193835</ArticleId><ArticleId IdType="pubmed">30015707</ArticleId></ArticleIdList></Reference><Reference><Citation>Ikeda K, Hirayama T, Takazawa T, Kawabe K, Iwasaki Y. Relationships between disease progression and serum levels of lipid, urate, creatinine and ferritin in Japanese patients with amyotrophic lateral sclerosis: a cross&#x2010;sectional study. Intern Med. 2012;51(12):1501&#x2010;1508. doi:10.2169/internalmedicine.51.7465</Citation><ArticleIdList><ArticleId IdType="doi">10.2169/internalmedicine.51.7465</ArticleId><ArticleId IdType="pubmed">22728481</ArticleId></ArticleIdList></Reference><Reference><Citation>Povedano M, Paipa A, Barcel&#xf3; M, et&#xa0;al. Plasma exchange with albumin replacement and disease progression in amyotrophic lateral sclerosis: a pilot study. Neurol Sci. 2022;43(5):3211&#x2010;3221. doi:10.1007/s10072-021-05723-z</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s10072-021-05723-z</ArticleId><ArticleId IdType="pmc">PMC9018657</ArticleId><ArticleId IdType="pubmed">34791571</ArticleId></ArticleIdList></Reference><Reference><Citation>Chi&#xf2; A, Calvo A, Bovio G, et&#xa0;al. Amyotrophic lateral sclerosis outcome measures and the role of albumin and creatinine: a population&#x2010;based study. JAMA Neurol. 2014;71(9):1134&#x2010;1142. doi:10.1001/jamaneurol.2014.1129</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/jamaneurol.2014.1129</ArticleId><ArticleId IdType="pubmed">25048026</ArticleId></ArticleIdList></Reference><Reference><Citation>Grosskreutz J, Van Den Bosch L, Keller BU. Calcium dysregulation in amyotrophic lateral sclerosis. Cell Calcium. 2010;47(2):165&#x2010;174. doi:10.1016/j.ceca.2009.12.002</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.ceca.2009.12.002</ArticleId><ArticleId IdType="pubmed">20116097</ArticleId></ArticleIdList></Reference><Reference><Citation>Mandrioli J, Rosi E, Fini N, et&#xa0;al. Changes in routine laboratory tests and survival in amyotrophic lateral sclerosis. Neurol Sci. 2017;38(12):2177&#x2010;2182. doi:10.1007/s10072-017-3138-8</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s10072-017-3138-8</ArticleId><ArticleId IdType="pubmed">28980128</ArticleId></ArticleIdList></Reference><Reference><Citation>Carreiro AV, Amaral PMT, Pinto S, Tom&#xe1;s P, de Carvalho M, Madeira SC. Prognostic models based on patient snapshots and time windows: predicting disease progression to assisted ventilation in amyotrophic lateral sclerosis. J Biomed Inform. 2015;58:133&#x2010;144. doi:10.1016/j.jbi.2015.09.021</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jbi.2015.09.021</ArticleId><ArticleId IdType="pubmed">26455265</ArticleId></ArticleIdList></Reference><Reference><Citation>Pfohl SR, Kim RB, Coan GS, Mitchell CS. Unraveling the complexity of amyotrophic lateral sclerosis survival prediction. Front Neuroinform. 2018;12:36. doi:10.3389/fninf.2018.00036</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fninf.2018.00036</ArticleId><ArticleId IdType="pmc">PMC6010549</ArticleId><ArticleId IdType="pubmed">29962944</ArticleId></ArticleIdList></Reference><Reference><Citation>Pancotti C, Birolo G, Rollo C, et&#xa0;al. Deep learning methods to predict amyotrophic lateral sclerosis disease progression. Sci Rep. 2022;12(1):13738. doi:10.1038/s41598-022-17805-9</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41598-022-17805-9</ArticleId><ArticleId IdType="pmc">PMC9374680</ArticleId><ArticleId IdType="pubmed">35962027</ArticleId></ArticleIdList></Reference><Reference><Citation>Balendra R, Jones A, Jivraj N, et&#xa0;al. Estimating clinical stage of amyotrophic lateral sclerosis from the ALS functional rating scale. Amyotroph Lateral Scler Frontotemporal Degener. 2014;15(3&#x2013;4):279&#x2010;284. doi:10.3109/21678421.2014.897357</Citation><ArticleIdList><ArticleId IdType="doi">10.3109/21678421.2014.897357</ArticleId><ArticleId IdType="pubmed">24720420</ArticleId></ArticleIdList></Reference><Reference><Citation>Chi&#xf2; A, Hammond ER, Mora G, Bonito V, Filippini G. Development and evaluation of a clinical staging system for amyotrophic lateral sclerosis. J Neurol Neurosurg Psychiatry. 2015;86(1):38&#x2010;44. doi:10.1136/jnnp-2013-306589</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/jnnp-2013-306589</ArticleId><ArticleId IdType="pubmed">24336810</ArticleId></ArticleIdList></Reference><Reference><Citation>Lunetta C, Lizio A, Melazzini MG, Maestri E, Sansone VA. Amyotrophic lateral sclerosis survival score (ALS&#x2010;SS): a simple scoring system for early prediction of patient survival. Amyotroph Lateral Scler Frontotemporal Degener. 2015;17(1&#x2013;2):93&#x2010;100. doi:10.3109/21678421.2015.1083585</Citation><ArticleIdList><ArticleId IdType="doi">10.3109/21678421.2015.1083585</ArticleId><ArticleId IdType="pubmed">26470943</ArticleId></ArticleIdList></Reference><Reference><Citation>Van Houwelingen HC, Putter H. Dynamic Prediction in Clinical Survival Analysis. CRC Press; 2012.</Citation></Reference><Reference><Citation>Wu C, Li L, Li R. Dynamic prediction of competing risk events using landmark sub&#x2010;distribution hazard model with multiple longitudinal biomarkers. Stat Methods Med Res. 2020;29(11):3179&#x2010;3191. doi:10.1177/0962280220921553</Citation><ArticleIdList><ArticleId IdType="doi">10.1177/0962280220921553</ArticleId><ArticleId IdType="pubmed">32419611</ArticleId></ArticleIdList></Reference><Reference><Citation>Klein JP, van Houwelingen HC, Ibrahim JG, Scheike TH. Handbook of Survival Analysis, Chapter 21. Landmarking. Chapman &amp; Hall/CRC Press; 2014:441&#x2010;456.</Citation></Reference><Reference><Citation>Rafiq MK, Lee E, Bradburn M, McDermott CJ, Shaw PJ. Creatine kinase enzyme level correlates positively with serum creatinine and lean body mass, and is a prognostic factor for survival in amyotrophic lateral sclerosis. Eur J Neurol. 2016;23(6):1071&#x2010;1078. doi:10.1111/ene.12995</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/ene.12995</ArticleId><ArticleId IdType="pubmed">27029589</ArticleId></ArticleIdList></Reference><Reference><Citation>Zach N, Ennist DL, Taylor AA, et&#xa0;al. Being PRO&#x2010;ACTive: what can a clinical trial database reveal about ALS? Neurotherapeutics. 2015;12(2):417&#x2010;423. doi:10.1007/s13311-015-0336-z</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s13311-015-0336-z</ArticleId><ArticleId IdType="pmc">PMC4404433</ArticleId><ArticleId IdType="pubmed">25613183</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle></PubmedArticleSet>